Procedural Sedation: Clinical Trials

3 trials for Procedural Sedation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Unknown 1, Withdrawn 1
Phase 22Completed 1, Unknown 1

Follow Procedural Sedation: new trials by email Literature Review of Procedural Sedation trials Research Report on Procedural Sedation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INK Feasibility Study
Intranasal ketamine - Procedural Sedation
Phase 3WithdrawnLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2024-01-012023-03-24
Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique
Ketamine Hydrochloride 50Mg/1mL Solution for Injection, Ketamine Hcl 50Mg/Ml Inj - Procedural Sedation
Phase 2 / Phase 3UnknownIsfahan University of Medical Sciences1982017-01-172018-04-17
A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.
AQUAVAN® (fospropofol disodium) Injection - Procedural Sedation
Phase 2 / Phase 3CompletedEisai Inc.1232006-05-012012-06-20

Narrower conditions

Arteriovenous Fistula (1)  ·  Bunion (1)  ·  Dilatation, Pathologic (1)

Broader conditions

Arteriovenous Malformations (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Fistula (1)  ·  Foot Deformities (1)  ·  Foot Deformities, Acquired (1)  ·  Musculoskeletal Diseases (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)  ·  Vascular Fistula (1)  ·  Vascular Malformations (1)

Interventions

Injections (2)  ·  Ketamine (1)  ·  Solutions (1)  ·  fospropofol (1)

Sponsors

Eisai Inc. (1)  ·  Isfahan University of Medical Sciences (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

Iran (1)  ·  United States (1)

Top investigators

James B Jones, MD, PharmD (1)  ·  Mehdi Nasr Isfahani, M.D. (1)